Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1086067.RAcPm3yk-HB11tm8LjTYjvovi5vt3s0HN6IxQZALpDejg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1086067.RAcPm3yk-HB11tm8LjTYjvovi5vt3s0HN6IxQZALpDejg130_assertion type Assertion NP1086067.RAcPm3yk-HB11tm8LjTYjvovi5vt3s0HN6IxQZALpDejg130_head.
- NP1086067.RAcPm3yk-HB11tm8LjTYjvovi5vt3s0HN6IxQZALpDejg130_assertion description "[P-glycoprotein is a product of the multidrug resistance (MDR1) gene, which is a major cause of the refractoriness of malignant lymphomas to conventional chemotherapeutic regimens containing anthracycline.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1086067.RAcPm3yk-HB11tm8LjTYjvovi5vt3s0HN6IxQZALpDejg130_provenance.
- NP1086067.RAcPm3yk-HB11tm8LjTYjvovi5vt3s0HN6IxQZALpDejg130_assertion evidence source_evidence_literature NP1086067.RAcPm3yk-HB11tm8LjTYjvovi5vt3s0HN6IxQZALpDejg130_provenance.
- NP1086067.RAcPm3yk-HB11tm8LjTYjvovi5vt3s0HN6IxQZALpDejg130_assertion SIO_000772 23768637 NP1086067.RAcPm3yk-HB11tm8LjTYjvovi5vt3s0HN6IxQZALpDejg130_provenance.
- NP1086067.RAcPm3yk-HB11tm8LjTYjvovi5vt3s0HN6IxQZALpDejg130_assertion wasDerivedFrom befree-2016 NP1086067.RAcPm3yk-HB11tm8LjTYjvovi5vt3s0HN6IxQZALpDejg130_provenance.
- NP1086067.RAcPm3yk-HB11tm8LjTYjvovi5vt3s0HN6IxQZALpDejg130_assertion wasGeneratedBy ECO_0000203 NP1086067.RAcPm3yk-HB11tm8LjTYjvovi5vt3s0HN6IxQZALpDejg130_provenance.